top of page
Jun 14
March 2024 Newsletter: Women's History Month Edition
Hello friends and colleagues, As we reflect on Women’s History Month, we would like to take the opportunity to shine a spotlight on...
Jun 14
February 2024 Newsletter: Leap Day Edition
Hello friends and colleagues, As we close out a short month packed with major updates and announcements, we are using this Leap Day to...
Jun 14
January 2024 Newsletter
Greetings friends and colleagues, Happy New Year and welcome to our first newsletter of 2024! As we usher in another promising year, we...
Dec 12, 2022
Prioritizing R&D Initiatives in Today’s Market
Dear Readers, As our economy continues to change, we thought it would be helpful to share some insights and industry patterns that we...
Sep 12, 2022
Our Approach to Storytelling
Dear friends and colleagues, “Biotech’s flameout,” “bloodbath,” “thousands of layoffs.” We’ve all heard it, and we’re in it. Whether...
Jul 29, 2022
5 Must-Have Slides for Investor Pitch Decks
To help our readers prepare for their next financing round, we’ve compiled a list of the 5 must-have slides for any investor pitch deck....
Jul 29, 2022
Tips for Navigating a Conference
Dear Readers, As we gear up for conference season, we thought it could be helpful to share some tips on how to succeed while at a...
Dec 8, 2021
Developments in Ulcerative Colitis
Many of our clients are pursuing groundbreaking therapies in disease areas with high unmet medical needs, giving our firm the chance to...
Aug 5, 2021
Top 5 uncertainties we tackle when creating revenue forecast models
One of our most sought-after commercial strategy services is the creation of revenue forecasts. As such, we’ve spent numerous projects...
May 26, 2021
Recent advances in antisense oligonucleotide therapy development
Our work at Headland covers a wide range of diseases and therapeutic areas, and we try to stay abreast of recent news and developments in...
Dec 23, 2020
The mystery of risk-taking in biotech (US, Japan)
As we’ve expanded our US-Japan services, we are often asked about the differences between the US and Japanese biopharma industry. There...
Aug 7, 2020
BIO 2020 Highlights
Last month we attended the first completely virtual BIO conference. We met with many innovative companies and are looking forward to...
Aug 7, 2020
Initiative on Racial Justice and Equality
A note from our CEO, President, and Founder: My team and I are deeply troubled by the ongoing examples of violence, cruelty, and...
bottom of page